• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.83% Nasdaq Up 1.02%

    Sinovac Biotech Ltd. (SVA)

    -NasdaqGS
    5.22 Up 0.02(0.38%) 11:11AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.20
    Open:5.25
    Bid:5.19 x 100
    Ask:5.22 x 200
    1y Target Est:7.50
    Beta:-0.053825
    Earnings Date:Nov 13 - Nov 16 (Est.)
    Day's Range:5.15 - 5.25
    52wk Range:4.51 - 6.00
    Volume:27,397
    Avg Vol (3m):113,931
    Market Cap:291.33M
    P/E (ttm):261.00
    EPS (ttm):0.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SVAUp 0.38%291.33M
    GSKUp 2.48%97.77B

    Key Statistics

    Forward P/E (1 yr):74.14
    P/S (ttm):4.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.05
    Quarterly EPS Est (Sep-15) :0.00
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-9.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against hepatitis A, hepatitis B, influenza viruses, and mumps in the People's Republic of China. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback